D. G. Krechikova

748 total citations
7 papers, 115 citations indexed

About

D. G. Krechikova is a scholar working on Rheumatology, Immunology and Pharmacology. According to data from OpenAlex, D. G. Krechikova has authored 7 papers receiving a total of 115 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 4 papers in Immunology and 1 paper in Pharmacology. Recurrent topics in D. G. Krechikova's work include Rheumatoid Arthritis Research and Therapies (4 papers), Biosimilars and Bioanalytical Methods (2 papers) and Psoriasis: Treatment and Pathogenesis (2 papers). D. G. Krechikova is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (4 papers), Biosimilars and Bioanalytical Methods (2 papers) and Psoriasis: Treatment and Pathogenesis (2 papers). D. G. Krechikova collaborates with scholars based in Russia, Belarus and Bulgaria. D. G. Krechikova's co-authors include Е. В. Зонова, Румен Стоилов, Eugen Feist, Saeed Fatenejad, Mariana Ivanova, Samsonov MIu, Mark C. Genovese, Mazurov Vi, P. А. Shesternya and Т. А. Раскина and has published in prestigious journals such as Annals of the Rheumatic Diseases, Clinical Therapeutics and Rheumatology Science and Practice.

In The Last Decade

D. G. Krechikova

6 papers receiving 108 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. G. Krechikova Russia	4	86	58	39	14	13	7	115
Rocío González-León Spain	6	98 1.1×	47 0.8×	14 0.4×	13 0.9×	7 0.5×	9	118
Sabrina Porta Argentina	4	134 1.6×	73 1.3×	11 0.3×	20 1.4×	9 0.7×	6	159
Clara Malagón Colombia	7	78 0.9×	47 0.8×	75 1.9×	11 0.8×	6 0.5×	11	141
S. Mouriès-Martin France	3	98 1.1×	67 1.2×	7 0.2×	25 1.8×	16 1.2×	4	121
DB Araújo Brazil	3	61 0.7×	21 0.4×	15 0.4×	12 0.9×	2 0.2×	4	67
Huoru Zhang China	5	89 1.0×	84 1.4×	6 0.2×	10 0.7×	12 0.9×	5	120
Mihaela Stegert Switzerland	4	56 0.7×	72 1.2×	16 0.4×	4 0.3×	4 0.3×	8	111
Magdolna Deák Hungary	4	54 0.6×	46 0.8×	19 0.5×	4 0.3×	12 0.9×	5	86
Ewa Bertolini France	6	35 0.4×	13 0.2×	12 0.3×	10 0.7×	18 1.4×	8	109
Mingxin Bai China	6	30 0.3×	41 0.7×	11 0.3×	4 0.3×	12 0.9×	18	91

Countries citing papers authored by D. G. Krechikova

Since Specialization

Citations

This map shows the geographic impact of D. G. Krechikova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. G. Krechikova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. G. Krechikova more than expected).

Fields of papers citing papers by D. G. Krechikova

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. G. Krechikova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. G. Krechikova. The network helps show where D. G. Krechikova may publish in the future.

Co-authorship network of co-authors of D. G. Krechikova

This figure shows the co-authorship network connecting the top 25 collaborators of D. G. Krechikova. A scholar is included among the top collaborators of D. G. Krechikova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. G. Krechikova. D. G. Krechikova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Yаkushin, S. S., et al.. (2021). Comparison of the Efficacy and Safety of Ketoprofen Plaster and Diclofenac Plaster for Osteoarthritis-Related Knee Pain: A Multicenter, Randomized, Active-Controlled, Open-Label, Parallel-Group, Phase III Clinical Trial. Clinical Therapeutics. 43(10). 1720–1734. 2 indexed citations

Fatenejad, Saeed, Eugen Feist, Mariana Ivanova, et al.. (2021). Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by methotrexate: efficacy and safety results of a randomised controlled phase III study. Annals of the Rheumatic Diseases. 81(4). 469–479. 50 indexed citations

Эрдес, Ш. Ф., Е. Л. Насонов, P. А. Shesternya, et al.. (2020). Primary efficacy of netakimab, a novel interleukin-17 inhibitor, in the treatment of active ankylosing spondylitis in adults.. PubMed. 38(1). 27–34. 34 indexed citations

Козырев, О. А., et al.. (2020). Challenges in diagnostics of microscopic polyangiitis in day to day practice. Vrach. 31(8). 87–88.

Vi, Mazurov, Ш. Ф. Эрдес, P. А. Shesternya, et al.. (2018). OP0028 Efficacy and safety of bcd-085, a novel il-17 inhibitor, in ankylosing spondylitis. results of phase 2 clinical study. Annals of the Rheumatic Diseases. 77. 64–64. 7 indexed citations

Vi, Mazurov, И. Г. Гордеев, O. B. Nesmeyanova, et al.. (2018). SAT0206 Results of the alterra clinical trial – the efficacy of the alternative dosing regimen for rituximab biosimilar in bdmards naive patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 77. 963–963. 1 indexed citations

Nasonov, E L, Е. В. Зонова, О.Н. Иванова, et al.. (2016). THE RESULTS OF A PHASE III COMPARATIVE CLINICAL TRIAL OF RITUXIMAB (ACELLBIA® AND MABTHERA®) IN RHEUMATOID ARTHRITIS (THE BIORA STUDY). Rheumatology Science and Practice. 54(5). 510–519. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact